Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
bIAP pharmacokinetic pilot study in CABG patients without aprotinin
NL-OMON32994Phase 2Not yet recruiting
- Sponsor
- Catharina Ziekenhuis
- Start
- Mar 2009
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bovine intestinal alkaline phosphatase in Systemic Inflammatory Response Syndrome (SIRS) (3 arms), sponsored by Catharina Ziekenhuis. Planned start Mar 2009; status: not yet recruiting.
02
Drugs
bovine intestinal alkaline phosphatase
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NL-OMON32994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32994.